Specify a stock or a cryptocurrency in the search bar to get a summary
LBT Innovations Ltd
LBTLBT Innovations Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia. Address: 16 Anster Street, Adelaide, SA, Australia, 5000
Analytics
WallStreet Target Price
0.3 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures LBT
Dividend Analytics LBT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LBT
Stock Valuation LBT
Financials LBT
Results | 2019 | Dynamics |